VioQuest Pharmaceuticals, Inc.
VOQP
$0.00
$0.000.00%
OTC PK
06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | 06/30/2007 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 554.80K | 690.30K | 285.90K | 1.20M | 1.19M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 1.03M | 1.67M | 1.48M | 2.67M | 2.14M |
Operating Income | -1.03M | -1.67M | -1.48M | -2.67M | -2.14M |
Income Before Tax | -1.13M | -3.08M | -3.26M | -3.22M | -2.14M |
Income Tax Expenses | -- | -- | -240.70K | -- | -- |
Earnings from Continuing Operations | -1.13M | -3.08M | -3.02M | -3.22M | -2.14M |
Earnings from Discontinued Operations | -- | -- | -500.00 | 333.70K | -335.40K |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -1.13M | -3.08M | -3.02M | -2.88M | -2.47M |
EBIT | -1.03M | -1.67M | -1.48M | -2.67M | -2.14M |
EBITDA | -1.03M | -1.67M | -1.48M | -2.67M | -2.14M |
EPS Basic | -0.38 | -0.63 | -0.62 | -0.63 | -0.65 |
Normalized Basic EPS | -0.14 | -0.39 | -0.27 | -0.44 | -0.35 |
EPS Diluted | -0.38 | -0.63 | -0.62 | -0.63 | -0.65 |
Normalized Diluted EPS | -0.14 | -0.39 | -0.27 | -0.44 | -0.35 |
Average Basic Shares Outstanding | 4.91M | 4.91M | 4.87M | 4.61M | 3.82M |
Average Diluted Shares Outstanding | 4.91M | 4.91M | 4.87M | 4.61M | 3.82M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |